MARKET

AZN

AZN

Astrazeneca Plc
NASDAQ
78.54
+0.36
+0.46%
After Hours: 78.25 -0.3 -0.38% 19:47 05/24 EDT
OPEN
78.13
PREV CLOSE
78.18
HIGH
78.89
LOW
78.08
VOLUME
3.57M
TURNOVER
0
52 WEEK HIGH
79.36
52 WEEK LOW
59.55
MARKET CAP
243.51B
P/E (TTM)
38.74
1D
5D
1M
3M
1Y
5Y
Wall Street Breakfast: The Week Ahead
Wall Street Breakfast looks at the week ahead. The first quarter earnings season is winding down, but Costco and Salesforce will report this week. Investors will be paying close attention to Friday's personal income and outlays data. The most overbought and oversold stocks are in the options market.
Seeking Alpha · 5h ago
Week In Review: Hengrui And Dearon Announce $7.2B In Drug Licensings
Seeking Alpha · 10h ago
Catalyst Watch: Costco earnings, M&A drama, Viking ratings, and a key inflation read
Seeking Alpha's Catalyst Watch includes a breakdown of next week's key events. The stock markets will be closed on Monday for Memorial Day holiday. The most overbought stocks are Barnes & Noble Education and Solowin. The quiet period ends on Viking Holdings (VIK) on May 29. Capri Holdings will report earnings and there will be some M&A drama.
Seeking Alpha · 1d ago
UPDATE 1-US natgas prices fall 5% to one-week low on rising output
US gas futures fall 5% to one-week low on rising output and forecasts for lower demand in two weeks. Analysts forecast gas stockpiles were about 27% above levels for this time of year. Power prices in Texas soar for Friday ahead of the long Memorial Day weekend.
Reuters · 1d ago
Pharma Stock Roundup: AZN's 2030 Sales Target, PFE's New Cost Cut Plan & More
NASDAQ · 2d ago
AstraZeneca: Plotting A Bold Path To $80 Billion Revenues, I'm Pausing For Breath
Seeking Alpha · 2d ago
AstraZeneca’s Growth Trajectory: A Buy Rating Justified by Strong Pipeline and Revenue Targets
TipRanks · 2d ago
Biden Administration Urges Supreme Court Review in Terrorism Funding Lawsuit Against Pharma Companies
The Justice Department has urged the Supreme Court to reconsider a ruling involving 21 pharmaceutical and medical equipment companies accused of funding terrorism in Iraq. The companies allegedly engaged in corrupt practices to secure contracts with a militia backed by Hezbollah. Hundreds of American service members and civilians filed a lawsuit in 2017 against the companies under the Anti-Terrorism Act. The Justice Department believes a precedent set in a previous case involving Twitter undermines the case.
Benzinga · 2d ago
More
About AZN
AstraZeneca PLC is a science-led biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of prescription medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory and immunology. Its pipeline forms a portfolio of investigational therapies in various stages of clinical development and includes the Alexion Rare Disease portfolio comprising approximately 178 projects. Its key marketed oncology products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Zoladex, Faslodex and others. Its rare diseases products include Soliris, Ultomiris, Strensiq and Kanuma. Its BioPharmaceuticals products include Farxiga, Lokelma, Crestor, Breztri and others. It is also focused on discovering, developing, and manufacturing of T-cell receptor therapies. It also offers investigational vaccine candidate IVX-A12, which targets both respiratory syncytial virus and human metapneumovirus.

Webull offers AstraZeneca plc (ADR) stock information, including NASDAQ: AZN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AZN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AZN stock methods without spending real money on the virtual paper trading platform.